CFA
TECH icon

Camarda Financial Advisors’s Bio-Techne TECH Stock Holding History

Camarda Financial Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16
Closed -$1K – 411
2019
Q2 		$1K Hold
16
– – ﹤0.01% 463
2019
Q1 		$1K Buy
+16
New +$720 ﹤0.01% 502

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Camarda Financial Advisors's TECH Position: Q3 2019 in Review

Camarda Financial Advisors sold out of Bio-Techne (TECH) in Q3 2019, closing a stake of 16 shares — an estimated $1K sold.

Camarda Financial Advisors first reported a position in TECH in Q1 2019 and held it in 2 quarters. The position peaked at $1K in Q2 2019. 341 funds tracked by Wall St. Rank hold TECH as of Q3 2019.

  • Camarda Financial Advisors reported no remaining Bio-Techne position as of Q3 2019 after selling out during the quarter.
  • Camarda Financial Advisors sold 16 Bio-Techne shares in Q3 2019, an estimated $1K.
  • Camarda Financial Advisors first reported a position in Bio-Techne in Q1 2019 and held it in 2 quarters.
  • Camarda Financial Advisors's Bio-Techne position peaked at $1K in Q2 2019.
  • 341 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2019.

Based on Camarda Financial Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.